MetaCap

Bristol-Myers Squibb Insider Trades

NYSE: BMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

59.12-0.46 (-0.77%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
4 · $2.29M
Shares bought / sold
0 / 36.75K
Net activity
Net selling $2.3 million

Bristol-Myers Squibb insider activity

Over the last 12 months, Bristol-Myers Squibb insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 4 sales. Insiders bought $0 and sold $2.3 million worth of stock, for net insider selling of $2.3 million. The largest seller was Elkins David V, with $1.9 million in reported sales.

The most recent filing shows Gallman Cari (EVP, General Counsel) reporting a transaction in 4,559 shares on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BMY's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BMY insider transactions

Bristol-Myers Squibb insider transactions
DateInsiderTypeSharesValueFiling
Oct 2, 2026Gallman CariEVP, General CounselTax withholding2,332$142.60KForm 4
Oct 2, 2026Gallman CariEVP, General CounselOption exercise4,559—Form 4
Sep 9, 2026Massacesi CristianEVP,Chief Med Offr,Head of DevSale6,249$403.50KForm 4
Sep 1, 2026Short Bartie WendyEVP, Corporate AffairsTax withholding633$42.36KForm 4
Sep 1, 2026Short Bartie WendyEVP, Corporate AffairsOption exercise1,236$82.71KForm 4
Aug 25, 2026Holzer Phil MSVP and ControllerSale500$33.75KForm 4
Aug 1, 2026Gallman CariEVP, General CounselTax withholding543$35.46KForm 4
Aug 1, 2026Gallman CariEVP, General CounselOption exercise1,061—Form 4
Aug 1, 2026Massacesi CristianEVP,Chief Med Offr,Head of DevTax withholding26,175$1.71MForm 4
Aug 1, 2026Massacesi CristianEVP,Chief Med Offr,Head of DevOption exercise51,172—Form 4
Jun 15, 2026Haller Julia ADirectorOption exercise20,460$1.10MForm 4
Jun 3, 2026Short Bartie WendyEVP, Corporate AffairsTax withholding3,876$212.09KForm 4
Jun 3, 2026Short Bartie WendyEVP, Corporate AffairsOption exercise8,040—Form 4
May 1, 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding599$34.87KForm 4
May 1, 2026Lenkowsky AdamEVP, Chief Commercial Officerother203—Form 4
May 1, 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise1,373—Form 4
Apr 1, 2026Elkins David VEVP, Chief Financial OfficerSale4,481$278.05KForm 4
Apr 1, 2026Elkins David VEVP, Chief Financial OfficerSale25,519$1.57MForm 4
Apr 1, 2026Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding1,692$104.45KForm 4
Apr 1, 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise3,307—Form 4
Mar 10, 2026Poole Ahn AmandaEVP, Chief People Officerother87—Form 4
Mar 10, 2026Poole Ahn AmandaEVP, Chief People OfficerOption exercise803—Form 4
Mar 10, 2026Poole Ahn AmandaEVP, Chief People OfficerTax withholding369$22.19KForm 4
Mar 10, 2026Poole Ahn AmandaEVP, Chief People Officerother91—Form 4
Mar 10, 2026Poole Ahn AmandaEVP, Chief People OfficerOption exercise811—Form 4
Mar 10, 2026Gallman CariEVP, General CounselTax withholding1,354$81.42KForm 4
Mar 10, 2026Gallman CariEVP, General Counselother2,554—Form 4
Mar 10, 2026Gallman CariEVP, General CounselOption exercise5,201—Form 4
Mar 10, 2026Gallman CariEVP, General CounselTax withholding396$23.81KForm 4
Mar 10, 2026Gallman CariEVP, General Counselother94—Form 4
Mar 10, 2026Gallman CariEVP, General CounselOption exercise867—Form 4
Mar 10, 2026Gallman CariEVP, General CounselTax withholding415$24.95KForm 4
Mar 10, 2026Gallman CariEVP, General Counselother102—Form 4
Mar 10, 2026Gallman CariEVP, General CounselOption exercise912—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Tax withholding912$54.84KForm 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.other3,095—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Option exercise6,304—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Tax withholding267$16.05KForm 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.other113—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Option exercise1,050—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Tax withholding212$12.75KForm 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.other94—Form 4
Mar 10, 2026Hoch LynellePresident, Cell Therapy Org.Option exercise838—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerTax withholding849$51.05KForm 4
Mar 10, 2026Holzer Phil MSVP and Controllerother2,264—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerOption exercise4,612—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerTax withholding248$14.91KForm 4
Mar 10, 2026Holzer Phil MSVP and Controllerother83—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerOption exercise768—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerTax withholding261$15.69KForm 4
Mar 10, 2026Holzer Phil MSVP and Controllerother91—Form 4
Mar 10, 2026Holzer Phil MSVP and ControllerOption exercise811—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding5,145$309.37KForm 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother9,702—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise19,760—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding1,503$90.38KForm 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother356—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise3,293—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsTax withholding1,112$66.86KForm 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & Opsother275—Form 4
Mar 10, 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise2,448—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding2,146$129.04KForm 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial Officerother4,046—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise8,241—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding3,125$187.91KForm 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial Officerother5,893—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise12,002—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding913$54.90KForm 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial Officerother216—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise2,000—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withholding831$49.97KForm 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial Officerother205—Form 4
Mar 10, 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise1,828—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withholding4,267$256.57KForm 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.other9,702—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Option exercise19,760—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withholding1,246$74.92KForm 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.other356—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Option exercise3,293—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withholding1,069$64.28KForm 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.other319—Form 4
Mar 10, 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Option exercise2,839—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerTax withholding3,172$190.73KForm 4
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother6,900—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerOption exercise14,052—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerTax withholding927$55.74KForm 4
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother253—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerOption exercise2,342—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerTax withholding436$26.22KForm 4
Mar 10, 2026Plenge Robert MEVP, Chief Research Officerother124—Form 4
Mar 10, 2026Plenge Robert MEVP, Chief Research OfficerOption exercise1,107—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsTax withholding828$49.79KForm 4
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother2,207—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsOption exercise4,495—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsTax withholding242$14.55KForm 4
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother81—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsOption exercise749—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsTax withholding205$12.33KForm 4
Mar 10, 2026Short Bartie WendyEVP, Corporate Affairsother72—Form 4
Mar 10, 2026Short Bartie WendyEVP, Corporate AffairsOption exercise639—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related